Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,920.10",
    "chg": 19.6,
    "chgp": "1.03%",
    "dir": 1,
    "prev_price": "1,900.50",
    "mcapval": "458,645.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "Aug 28, 03:30 PM",
    "curr_time": "13:15 PM",
    "last_traded_at": "Aug 28, 03:30 PM IST",
    "bse_nse_vol": "13.35 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 28, 2026",
    "traded_date_str": "2026 08 28",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "P/E at 36.09 vs Industry's 37.19: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthening-its-position-in-the-nifty-50-amid-institutional-shifts-4172941",
        "imagepath": "",
        "date": "2026-08-28 09:25:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: A Slight Discount to Industry Average</strong></p>\n                <p>The P/E ratio of 36.09 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> suggests the stock is trading at a modest discount of approximately 3% relative to its sector peers. This contrasts with many large-cap pharmaceutical companies that often command significant premiums due to their scale and product portfolios. The industry P/E of 37.19 reflects a sector with generally elevated valuations, driven by growth expectations and innovation pipelines. The near-parity in valuation indicates that the market is pricing in steady earnings growth without excessive optimism or pessimism. This valuation context is cr..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4170896",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunPharmaceutic_technicaldot_4170896.png",
        "date": "2026-08-27 08:03:52",
        "description": "Sun Pharmaceutical Industries Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a slight dip in the stock price, the underlying technical framework suggests cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Upgraded to Buy on Strong Technical and Fundamental Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-upgraded-to-buy-on-strong-technical-and-fundamental-signals-4169613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunPharmaceutic_mojoScore_4169613.png",
        "date": "2026-08-26 08:26:43",
        "description": "Sun Pharmaceutical Industries Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical outlook. This upgrade reflects improved technical momentum, robust long-term fundamentals, and a premium valuation justified by consistent market-beating returns and strong institutional backing."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-technical-momentum-shifts-signal-bullish-outlook-4169451",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunPharmaceutic_technicaldot_4169451.png",
        "date": "2026-08-26 08:04:16",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from a Hold to a Buy rating by MarketsMOJO, alongside improved moving averages and momentum oscillators, suggests growing investor confidence amid a strong price performance relative to the broader market."
      },
      {
        "title": "P/E at 36.27 vs Industry's 36.64: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-amid-mixed-market-signals-4168354",
        "imagepath": "",
        "date": "2026-08-25 09:21:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: A Close Match to Industry Norms</strong></p>\n                <p>The pharmaceutical giant's P/E ratio of 36.27 sits just below the Pharmaceuticals & Biotechnology sector average of 36.64, signalling that the market values <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> in line with its peers. This valuation level suggests investors are pricing in steady earnings growth consistent with sector expectations rather than a significant premium or discount. Given the company's large-cap status with a market capitalisation of ₹4,58,249 crores, this alignment with industry valuation metrics reflects a mature market perception of its earnings stability and growth prospects. However, <a hr..."
      },
      {
        "title": "P/E at 36.10 vs Industry's 36.64: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-4166477",
        "imagepath": "",
        "date": "2026-08-24 09:21:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Slight Discount Amid Sector Parity</strong></p>\n                <p>The current P/E of 36.10 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> sits marginally below the Pharmaceuticals &amp; Biotechnology industry average of 36.64. This near parity suggests that the market values the company’s earnings in line with its sector peers, reflecting neither a significant premium nor a discount. Given the large-cap status with a market capitalisation of ₹4,55,381.78 crores, this valuation level implies a degree of confidence in the company’s earnings stability relative to the broader industry. However, the slight discount could also indicate some caution among investors, possibly lin..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Falls 1.25%: 2 Key Factors Driving the Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-falls-125-2-key-factors-driving-the-weekly-move-4165257",
        "imagepath": "",
        "date": "2026-08-22 14:03:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> Stock opens at Rs.1,924.90, declines 2.20% amid technical momentum shift</p>\n                    <p><strong>18 Aug:</strong> Technical momentum shifts to mildly bullish despite price drop to Rs.1,882.50</p>\n                    <p><strong>21 Aug:</strong> Open interest surges 11.9% in derivatives, stock closes at Rs.1,900.90</p>\n                    <p><strong>21 Aug:</strong> Week ends with stock down 1.25%, Sensex down 0.40%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,924.90</div></div>\n                    <div class=\"stat-item\"><d..."
      },
      {
        "title": "Sun Pharmaceutical Sees Notable Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-notable-open-interest-surge-amid-mixed-market-signals-4164429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunPharmaceutic_oi_spurts_by_underlying_4164429.png",
        "date": "2026-08-21 15:00:55",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market activity and shifting positioning among traders. Despite a modest decline in the stock price, the rise in open interest by 11.87% suggests fresh directional bets and heightened volatility expectations in the near term."
      },
      {
        "title": "P/E at 36.1 vs Industry's 36.8: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-market-dynamics-4163546",
        "imagepath": "",
        "date": "2026-08-21 09:21:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index confers considerable advantages and responsibilities on Sun Pharmaceutical Industries Ltd. The index, representing the top 50 companies by free-float market capitalisation on the National Stock Exchange, serves as a barometer for the Indian equity market. Inclusion ensures enhanced visibility among domestic and international institutional investors, increased liquidity, and eligibility for passive funds tracking the index. This status often translates into a more stable investor base and can influence the stock’s valuation multiples.</p>\n                <p>Sun Pharma’s market capitalisation currently stands at a robust ₹4,56,114 crores, firmly placing it in the large-c..."
      }
    ],
    "total": 1257,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "26-Aug-2026",
      "details": "Newspaper Advertisements about Postal Ballot/E-voting",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "25-Aug-2026",
      "details": "Notice of Postal Ballot/E-voting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "25-Aug-2026",
      "details": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Jul 26",
          "dt": "2026-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

P/E at 36.09 vs Industry's 37.19: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-28 09:25:59

Valuation Picture: A Slight Discount to Industry Average

The P/E ratio of 36.09 for Sun Pharmaceutical Industries Ltd suggests the stock is trading at a modest discount of approximately 3% relative to its sector peers. This contrasts with many large-cap pharmaceutical companies that often command significant premiums due to their scale and product portfolios. The industry P/E of 37.19 reflects a sector with generally elevated valuations, driven by growth expectations and innovation pipelines. The near-parity in valuation indicates that the market is pricing in steady earnings growth without excessive optimism or pessimism. This valuation context is cr...

Read full news article

Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-27 08:03:52

Sun Pharmaceutical Industries Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a slight dip in the stock price, the underlying technical framework suggests cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Sun Pharmaceutical Industries Ltd Upgraded to Buy on Strong Technical and Fundamental Signals

2026-08-26 08:26:43

Sun Pharmaceutical Industries Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical outlook. This upgrade reflects improved technical momentum, robust long-term fundamentals, and a premium valuation justified by consistent market-beating returns and strong institutional backing.

Read full news article

Sun Pharmaceutical Industries Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-26 08:04:16

Sun Pharmaceutical Industries Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from a Hold to a Buy rating by MarketsMOJO, alongside improved moving averages and momentum oscillators, suggests growing investor confidence amid a strong price performance relative to the broader market.

Read full news article

P/E at 36.27 vs Industry's 36.64: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-25 09:21:17

Valuation Picture: A Close Match to Industry Norms

The pharmaceutical giant's P/E ratio of 36.27 sits just below the Pharmaceuticals & Biotechnology sector average of 36.64, signalling that the market values Sun Pharmaceutical Industries Ltd in line with its peers. This valuation level suggests investors are pricing in steady earnings growth consistent with sector expectations rather than a significant premium or discount. Given the company's large-cap status with a market capitalisation of ₹4,58,249 crores, this alignment with industry valuation metrics reflects a mature market perception of its earnings stability and growth prospects. However, Read full news article

P/E at 36.10 vs Industry's 36.64: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-24 09:21:17

Valuation Picture: Slight Discount Amid Sector Parity

The current P/E of 36.10 for Sun Pharmaceutical Industries Ltd sits marginally below the Pharmaceuticals & Biotechnology industry average of 36.64. This near parity suggests that the market values the company’s earnings in line with its sector peers, reflecting neither a significant premium nor a discount. Given the large-cap status with a market capitalisation of ₹4,55,381.78 crores, this valuation level implies a degree of confidence in the company’s earnings stability relative to the broader industry. However, the slight discount could also indicate some caution among investors, possibly lin...

Read full news article

Sun Pharmaceutical Industries Ltd Falls 1.25%: 2 Key Factors Driving the Weekly Move

2026-08-22 14:03:24

Key Events This Week

17 Aug: Stock opens at Rs.1,924.90, declines 2.20% amid technical momentum shift

18 Aug: Technical momentum shifts to mildly bullish despite price drop to Rs.1,882.50

21 Aug: Open interest surges 11.9% in derivatives, stock closes at Rs.1,900.90

21 Aug: Week ends with stock down 1.25%, Sensex down 0.40%

Week Open

Rs.1,924.90

Read full news article

Sun Pharmaceutical Sees Notable Open Interest Surge Amid Mixed Market Signals

2026-08-21 15:00:55

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market activity and shifting positioning among traders. Despite a modest decline in the stock price, the rise in open interest by 11.87% suggests fresh directional bets and heightened volatility expectations in the near term.

Read full news article

P/E at 36.1 vs Industry's 36.8: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-08-21 09:21:04

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index confers considerable advantages and responsibilities on Sun Pharmaceutical Industries Ltd. The index, representing the top 50 companies by free-float market capitalisation on the National Stock Exchange, serves as a barometer for the Indian equity market. Inclusion ensures enhanced visibility among domestic and international institutional investors, increased liquidity, and eligibility for passive funds tracking the index. This status often translates into a more stable investor base and can influence the stock’s valuation multiples.

Sun Pharma’s market capitalisation currently stands at a robust ₹4,56,114 crores, firmly placing it in the large-c...

Read full news article

View All News